Skip to main content

Advertisement

Table 1 Characteristics of patients

From: Three-dimensional conformal radiotherapy with concurrent chemotherapy for postoperative recurrence of esophageal squamous cell carcinoma: clinical efficacy and failure pattern

Characteristics Patients (n = 83) No. (%)
Sex  
 Male 62 (74.7%)
 Female 21 (25.3%)
Age (year), median (range) 55, (37–80)
ECOG performance status  
 0-1 73 (88.0%)
 2-3 10 (12.0%)
Primary tumor location  
 Upper 9 (10.8%)
 Middle 62 (74.7%)
 Lower 12 (14.5%)
Radical surgery  
 Three-field resection 11 (13.3%)
 Two-field resection 72 (86.7%)
Histology of primary tumor (SCC)  
 G1-2 50 (60.2%)
 G3-4 33 (39.8%)
Stage of primary tumor (7th edition)  
 IA-IB 8 (9.6%)
 IIA-IIB 38 (45.8%)
 IIIA-IIIC 37 (44.6%)
Time between surgery and RT(month), median (range) 14 (2–88)
Recurrence site  
 Anastomosis with/without lymphadenopathy 20 (24.1%)
 Supraclavicular and/or regional lymph node 63 (75.9%)
RT dose (Gy), median (range) 60 (50–68)
Concurrent chemotherapy  
 cisplatin + 5-Fu 39 (47.0%)
 Docetaxel + cisplatin 44 (53.0%)
Tumor Response after CCRT  
 CR 37 (44.6%)
 PR 26 (31.3%)
 SD 11 (13.3%)
 PD 9 (10.8%)